Mark Horvath's most recent trade in Hologic, Inc. was a trade of 2,844 Non-qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Hologic, Inc. | Mark Horvath | Div. Pres., Breast & Skeletal | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 2,844 | 2,844 | - | - | Non-qualified Stock Option (Right to Buy) | |
Hologic, Inc. | Mark Horvath | Div. Pres., Breast & Skeletal | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 958 | 7,057 (0%) | 0% | - | Common Stock |